Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: a controlled study.
作者信息
Nilsen K H, Jayson M I, Dixon A S
出版信息
Br Med J. 1978 Oct 21;2(6145):1124. doi: 10.1136/bmj.2.6145.1124.
Abstract
摘要
相似文献
1
Microcrystalline calcium hydroxyapatite compound in corticosteroid-treated rheumatoid patients: a controlled study.皮质类固醇治疗的类风湿关节炎患者中的微晶羟基磷灰石化合物：一项对照研究。
Br Med J. 1978 Oct 21;2(6145):1124. doi: 10.1136/bmj.2.6145.1124.
2
Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention.
J Rheumatol. 1995 Jun;22(6):1013-9.
3
1,25-Dihydroxyvitamin D(3) may be insufficient to prevent corticosteroid-induced osteoporosis in patients with early rheumatoid arthritis: comment on the article by Colin et al.1,25-二羟维生素D(3)可能不足以预防早期类风湿关节炎患者的皮质类固醇诱导的骨质疏松症：对科林等人文章的评论
Arthritis Rheum. 2010 Oct;62(10):3125-6; author reply 3126. doi: 10.1002/art.27634.
4
Intermittent etidronate and corticosteroid-induced osteoporosis.
N Engl J Med. 1997 Dec 25;337(26):1921. doi: 10.1056/NEJM199712253372613.
5
Bone mass in corticosteroid treated patients with rheumatoid arthritis, asthma and polymyalgia rheumatica.接受皮质类固醇治疗的类风湿关节炎、哮喘和风湿性多肌痛患者的骨量
Scott Med J. 1985 Jan;30(1):54-5. doi: 10.1177/003693308503000115.
6
7
[Osteoporosis in rheumatoid arthritis and the possible potentiating effect of corticosteroids].
Acta Med Iugosl. 1985;39(1):75-84.
8
Posterior subcapsular cataracts and glaucoma associated with long-term oral corticosteroid therapy. In patients with rheumatoid arthritis and related conditions.长期口服皮质类固醇治疗相关的后囊下白内障和青光眼。见于类风湿性关节炎及相关病症患者。
Br J Ophthalmol. 1969 Jun;53(6):361-72. doi: 10.1136/bjo.53.6.361.
9
The power Doppler twinkling artefact associated with periarticular calcification induced by intra-articular corticosteroid injection in patients with rheumatoid arthritis.类风湿关节炎患者关节内注射皮质类固醇后关节周围钙化相关的能量多普勒闪烁伪像。
Ann Rheum Dis. 2013 Jul;72(7):1267-9. doi: 10.1136/annrheumdis-2012-202897. Epub 2013 Mar 16.
10
Corticoids in osteoporosis.骨质疏松症中的皮质类固醇。
Ann Intern Med. 1971 Jun;74(6):1013-4. doi: 10.7326/0003-4819-74-6-1013.
引用本文的文献
1
Corticosteroid-induced bone loss. Prevention and management.皮质类固醇诱导的骨质流失。预防与管理。
Drug Saf. 1996 Nov;15(5):347-59. doi: 10.2165/00002018-199615050-00005.
2
Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females.骨胶原-羟基磷灰石复合物与碳酸钙对骨质疏松女性治疗效果的比较
Osteoporos Int. 1995 Jan;5(1):30-4. doi: 10.1007/BF01623655.
3
Non-hormonal treatment of osteoporosis.
Br Med J (Clin Res Ed). 1983 May 21;286(6378):1647-8.
4
Non-hormonal treatment of osteoporosis.骨质疏松症的非激素治疗
Br Med J (Clin Res Ed). 1983 Mar 26;286(6370):999-1000. doi: 10.1136/bmj.286.6370.999.
5
Osteoporosis. An update on management.骨质疏松症。管理方面的最新进展。
Drugs. 1984 Dec;28(6):565-76. doi: 10.2165/00003495-198428060-00005.
6
Calcium metabolism in bone disease: effects of treatment with microcrystalline calcium hydroxyapatite compound and dihydrotachysterol.骨病中的钙代谢：微晶羟基磷灰石化合物与二氢速甾醇治疗的效果
J R Soc Med. 1980 Nov;73(11):780-5. doi: 10.1177/014107688007301106.
7
Steroid osteoporosis.类固醇性骨质疏松症
Calcif Tissue Int. 1989 Aug;45(2):63-7. doi: 10.1007/BF02561402.
本文引用的文献
1
The effect of protein intake on the absorption of calcium and magnesium.蛋白质摄入量对钙和镁吸收的影响。
Biochem J. 1942 Sep;36(7-9):686-91. doi: 10.1042/bj0360686.
2
Hypophosphataemic osteomalacia presenting in adults.
Q J Med. 1971 Apr;40(158):303-29. doi: 10.1093/oxfordjournals.qjmed.a067272.
3
The effect of whole-bone extract on 47Ca absorption in the elderly.全骨提取物对老年人47Ca吸收的影响。
Age Ageing. 1973 Nov;2(4):230-4. doi: 10.1093/ageing/2.4.230.
Zotero 插件